Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Gains from Sales and Divestitures (2023 - 2025)

Standard Biotools (LAB) has disclosed Gains from Sales and Divestitures for 3 consecutive years, with $8.2 million as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 2051.96% to $8.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.2 million through Dec 2025, up 2051.96% year-over-year, with the annual reading at $8.2 million for FY2025, 2051.96% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $8.2 million at Standard Biotools, up from $383000.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $8.2 million in Q4 2025, with the low at $52000.0 in Q4 2023.
  • Average Gains from Sales and Divestitures over 3 years is $2.4 million, with a median of $1.7 million recorded in 2024.
  • The sharpest move saw Gains from Sales and Divestitures skyrocketed 71.39% in 2024, then surged 2051.96% in 2025.
  • Over 3 years, Gains from Sales and Divestitures stood at $52000.0 in 2023, then soared by 636.54% to $383000.0 in 2024, then soared by 2051.96% to $8.2 million in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $8.2 million, $383000.0, and $4.0 million for Q4 2025, Q4 2024, and Q3 2024 respectively.